Clifford Chin

Clinical Focus

• Cardiology (Heart), Pediatric
• Cardiac Transplantation
• Pediatric Cardiology

Administrative Appointments

• Director, Pediatric Heart Transplant Services, Stanford University , (2006– present )
• Director, Pediatric Cardiopulmonary Exercise Laboratory, Lucile Packard Children's Hospital , (1995– present )

Professional Education

• Board Certification: Pediatric Cardiology, American Board of Pediatrics (1998)
• SUMC - Graduate Medical Education (1995) CA
• UC Davis Medical Center (1992) CA
• UC Davis Medical Center (1990) CA
• SUNY @ Brooklyn School Of Medicine (1989) NY
• Ped Cardiology, Stanford University Ped Cardiology (1995)
• Pediatrics, UC Davis Pediatrics (1992)
• B.A., Boston University Biology (1985)
• M.D., SUNY - Brooklyn Medicine (1989)

Graduate & Fellowship Program Affiliations

• Pediatrics

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. 

• Consulting: Belsky and Associates, Attorneys at Law, Klein and Babbitt, LLC, Attorneys at Law

Current Research Interests

1. Pediatric Heart Transplant: development of non-invasive evaluations for the determination of allograft rejection and coronary artery disease; post-transplant hyperlipidemia; prevention of graft coronary artery disease

2. Pediatric Exercise Testing: development of new techniques

Publications

• VO2@RER1.0: a novel submaximal cardiopulmonary exercise index. Chin C,  Kazmucha J, Kim N, Suryani R, Olson I.  Pediatr Cardiol.  2010; 31 (1): 50-5
• Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus. Potena L,  Fearon WF, Sydow K, Holweg C, Luikart H, Chin C, Weisshaar D, Mocarski ES, Lewis DB, Valantine HA, Cooke JP.  Transplantation.  2008; 85 (6): 827-33
• Prevention of pediatric graft coronary artery disease: atorvastatin. Chin C,  Lukito SS, Shek J, Bernstein D, Perry SB.  Pediatr Transplant.  2008; 12 (4): 442-6
• Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Potena L,  Holweg CT, Chin C, Luikart H, Weisshaar D, Narasimhan B, Fearon WF, Lewis DB, Cooke JP, Mocarski ES, Valantine HA.  Transplantation.  2006; 82 (3): 398-405
• Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study. Chow AY,  Chin C, Dahl G, Rosenthal DN.  J Clin Oncol.  2006; 24 (6): 925-8
• Ten- and 20-year survivors of pediatric orthotopic heart transplantation. Ross M,  Kouretas P, Gamberg P, Miller J, Burge M, Reitz B, Robbins R, Chin C, Bernstein D.  J Heart Lung Transplant.  2006; 25 (3): 261-70
• Cardiac re-transplantation in pediatrics: a multi-institutional study. Chin C,  Naftel D, Pahl E, Shankel T, Clark ML, Gamberg P, Kirklin J, Webber S.  J Heart Lung Transplant.  2006; 25 (12): 1420-4
• T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Tu W,  Potena L, Stepick-Biek P, Liu L, Dionis KY, Luikart H, Fearon WF, Holmes TH, Chin C, Cooke JP, Valantine HA, Mocarski ES, Lewis DB.  Circulation.  2006; 114 (15): 1608-15
• Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Bernstein D,  Naftel D, Chin C, Addonizio LJ, Gamberg P, Blume ED, Hsu D, Canter CE, Kirklin JK, Morrow WR.  Circulation.  2006; 114 (4): 273-80
• Pediatric cardiac transplantation. Alkhaldi A,  Chin C, Bernstein D.  Semin Pediatr Surg.  2006; 15 (3): 188-98
• Pharmacotherapy of hyperlipidemia in pediatric heart transplant recipients: current practice and future directions. Chin C,  Bernstein D.  Paediatr Drugs.  2005; 7 (6): 391-6
• Induction therapy for pediatric and adult heart transplantation: comparison between OKT3 and daclizumab. Chin C,  Pittson S, Luikart H, Bernstein D, Robbins R, Reitz B, Oyer P, Valantine H.  Transplantation.  2005; 80 (4): 477-81
• Experience of percutaneous coronary intervention in the management of pediatric cardiac allograft vasculopathy. Tham EB,  Yeung AC, Cheng CW, Bernstein D, Chin C, Feinstein JA.  J Heart Lung Transplant.  2005; 24 (6): 769-73
• Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data. Rosenthal DN,  Chin C, Nishimura K, Perry SB, Robbins RC, Reitz B, Bernstein D, Feinstein JA.  J Heart Lung Transplant.  2004; 23 (3): 323-9
• Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience. Chin C,  Naftel DC, Singh TP, Blume ED, Luikart H, Bernstein D, Gamberg P, Kirklin JK, Morrow WR.  J Heart Lung Transplant.  2004; 23 (2): 178-85
• Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients. Chin C,  Hunt S, Robbins R, Hoppe R, Reitz B, Bernstein D.  J Heart Lung Transplant.  2002; 21 (6): 667-73
• Efficacy and safety of atorvastatin after pediatric heart transplantation. Chin C,  Gamberg P, Miller J, Luikart H, Bernstein D.  J Heart Lung Transplant.  2002; 21 (11): 1213-7
• Efficacy and safety of atorvastatin after pediatric cardiac transplantation. Chin C,  Gamberg P, Miller J, Luikart H, Bernstein D.  J Heart Lung Transplant.  2001; 20 (2): 230
• Safety and utility of the routine surveillance biopsy in pediatric patients 2 years after heart transplantation. Chin C,  Akhtar MJ, Rosenthal DN, Bernstein D.  J Pediatr.  2000; 136 (2): 238-42
• Outcome while awaiting heart transplantation in children: a comparison of congenital heart disease and cardiomyopathy. Rosenthal DN,  Dubin AM, Chin C, Falco D, Gamberg P, Bernstein D.  J Heart Lung Transplant.  2000; 19 (8): 751-5
• Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients. Chin C,  Rosenthal D, Bernstein D.  Pediatr Transplant.  2000; 4 (3): 193-9
• QT dispersion predicts ventricular arrhythmia in pediatric cardiomyopathy patients referred for heart transplantation. Dubin AM,  Rosenthal DN, Chin C, Bernstein D.  J Heart Lung Transplant.  1999; 18 (8): 781-5
• Brachial artery reactivity: A modified technique with applicability to children. Rosenthal DN,  Chin C.  J Am Soc Echocardiogr.  1999; 12 (10): 850-2
• The use of advanced-age donor hearts adversely affects survival in pediatric heart transplantation. Chin C,  Miller J, Robbins R, Reitz B, Bernstein D.  Pediatr Transplant.  1999; 3 (4): 309-14
• A new therapeutic approach to the fetus with congenital complete heart block: preemptive, targeted therapy with dexamethasone. Rosenthal D,  Druzin M, Chin C, Dubin A.  Obstet Gynecol.  1998; 92 (4 Pt 2): 689-91
• Reversible cardiomyopathy in a child with Addison's disease. Derish M,  Eckert K, Chin C.  Intensive Care Med.  1996; 22 (5): 460-3
• Intraosseous Resuscitation of Hemorrhagic Shock in a Pediatric Animal Model Using a Low Sodium Hypertonic Fluid. Chin C.,  Sheikh A., Eaker J., et. al..  Critical Care Med.  1996; 24 (6)
• Arterial switch and resection of hepatic hemangioendothelioma. Robbins RC,  Chin C, Yun KL, Berry GJ, Bernstein D, Reitz BA.  Ann Thorac Surg.  1995; 59 (6): 1575-7
• Cardiomyopathy Induced by Phenylpropanolamine. Chin C.,  Michael Choy M..  J Pediatr.  1993; 123 (5)
• Fate of the Endocardial Cushions in the Developing Chick Heart. Chin C.,  Gandour-Edwards R., Oltjen S., Choy M..  Pediatr Res.  1992; 23 (4)